Stay updated with breaking news from Epic Bio. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
NANJING, China, Dec. 7, 2023 /PRNewswire/ -- The rapid advancement of technology has propelled the field of life sciences into unprecedented growth, constantly expanding our understanding and...
NANJING, China, Dec. 7, 2023 /PRNewswire/ -- The rapid advancement of technology has propelled the field of life sciences into unprecedented growth, constantly expanding our understanding and imagination. Particularly in the field of cellular gene therapy, a series of recent positive developments have been overwhelming. Recently, the world's first CRISPR/Cas9 gene editing therapy received market approval in the UK....
- Potential one-time therapy for the treatment of FSHD includes a novel non-cutting dCas protein delivered via a single AAV - - EPI-321 is the only...
07.11.2023 - Gilead Sciences, Inc. (Nasdaq: GILD) announced today its results of operations for the third quarter of 2023. “Gilead has now delivered two years of consistent growth in our base business. In the third quarter, this continued growth was driven by ...
- Epic’s non-cutting technology to modulate the epigenome advances with the addition of new hypercompact Cas effectors and potent gene activators -SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Epic Bio, a biotechnology company developing therapies to modulate gene expression using compact, non-cutting dCas proteins,...